Barrow Robert bought DFTX
February 3, 2026 · Form 4 insider transaction
Barrow Robert bought 320,000 shares of Definium Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
320,000
Price
$0.00
Total value
N/A
InsiderBarrow Robert
RoleOfficer, Director
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2026
Filing dateFebruary 5, 2026
Shares owned after1,098,477
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 1, 2026, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.